NonHodgkin Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which NonHodgkin Lymphoma trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

RecruitingNot Applicable

NCT01137643

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in…

United States15,000 participantsStarted 2009-07

Treatment: biologic sample preservation procedure, cytology specimen collection procedure

RecruitingNot Applicable

NCT00935090

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors pre…

United StatesStarted 2009-09

Treatment: 3'-deoxy-3'-[18F]fluorothymidine

RecruitingNot Applicable

NCT01137825

Registry of Older Patients With Cancer

RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering informa…

United States3,000 participantsStarted 2009-09

RecruitingNot Applicable

NCT02964858

Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.

The purpose of this study is to compare standard dose radiation of 45 Gray(Gy) in 25 fractions in Non Hodgkin's Lymphoma- Diffuse Large B cell Lymphoma (NHL-DLB…

India840 participantsStarted 2016-11

Treatment: Standard Arm, Experimental Arm

RecruitingPhase 2

NCT06462248

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

CAR-T therapy is now available as a commercial product for treatment of relapsed /refractory acute lymphoblastic leukaemia and B-lymphoma. There is limited acce…

China20 participantsStarted 2024-06-01

Treatment: CUCART19

All recent trials (100 shown)

Active — Not RecruitingNot Applicable

NCT00039676

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Background: * Individuals may be prone to develop blood or lymph node cancers (leukemia or lymphoma) for a variety of reasons, including genetic predisposition…

United States1,836 participantsStarted 2002-07-08

CompletedPhase 2

NCT01384513

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

This phase II trial studies how well reduced intensity donor stem cell transplant works in treating patients with hematologic malignancies. Giving chemotherapy…

United States40 participantsStarted 2011-08-04

Treatment: Fludarabine, Busulfan

NonHodgkin Lymphoma

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Registry of Older Patients With Cancer

Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

All recent trials (100 shown)

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Registry of Older Patients With Cancer

Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

All recent trials (100 shown)

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignanci…

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent…

A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma

Ipilimumab and Local Radiation for Selected Solid Tumors

Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin